Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis

Open Access

Peer-reviewed

Research Article

Joel Raffel ,

Contributed equally to this work with: Joel Raffel, Arie R. Gafson

* E-mail: joelraffel@doctors.org.uk

Affiliation Department of Medicine, Imperial College London, London, United Kingdom
⨯
Arie R. Gafson ,

Contributed equally to this work with: Joel Raffel, Arie R. Gafson

Affiliation Department of Medicine, Imperial College London, London, United Kingdom
⨯
Samer Dahdaleh,

Affiliation Department of Medicine, Imperial College London, London, United Kingdom
⨯
Omar Malik,

Affiliation Department of Medicine, Imperial College London, London, United Kingdom
⨯
Brynmor Jones,

Affiliation Department of Medicine, Imperial College London, London, United Kingdom
⨯
Richard Nicholas

Affiliation Department of Medicine, Imperial College London, London, United Kingdom
⨯

Reader Comments (0)

Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Inflammatory diseases
Is the Subject Area "Inflammatory diseases" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Forecasting
Is the Subject Area "Forecasting" applicable to this article?

Thanks for your feedback.
Multiple sclerosis
Is the Subject Area "Multiple sclerosis" applicable to this article?

Thanks for your feedback.
Survival analysis
Is the Subject Area "Survival analysis" applicable to this article?

Thanks for your feedback.